SEER — what changed in the latest 10-Q
A section-by-section comparison of SEER's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-11 vs the prior 10-Q · 2026-05-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +10 | −3 | ~12 | 29 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Text added/removed | +3 | 0 | ~6 | 363 |
| Other information | No paragraph-level changes | 0 | 0 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-11
Comparisons of the Three Months Ended June 30, 2026 and 2025
Selling, general and administrative expenses for the three months ended June 30, 2026 decreased by $0.5 million, or 5%, compared to the same period in 2025. The decrease was primarily driven by lower employee compensation costs of $1.1 million and stock-based compensation of $1.1 million, partially …
The following table summarizes our results of operations for the periods presented:
Revenue for the six months ended June 30, 2026 decreased by $2.4 million, or 29%, compared to the same period in 2025. The decrease was due to lower product sales and service revenue during the period.
Cost of revenue for the six months ended June 30, 2026 decreased by $0.7 million, or 17%, compared to the same period in 2025. The decrease was primarily due to lower service revenue.
Text removed vs the prior filing · source: 10-Q · 2026-05-13
Selling, general and administrative expenses for the three months ended March 31, 2026 decreased by $2.0 million, or 18%, compared to the three months ended March 31, 2025. The decrease was primarily due to a $1.4 million decrease in stock-based compensation and a $0.6 million decrease in employee c…
During the three months ended March 31, 2026, cash used in financing activities was $2.6 million, which was primarily attributable to the repurchases of Class A common stock under our share repurchase program.
During the three months ended March 31, 2025, cash used in financing activities was $1.5 million, which was primarily attributable to the taxes withholding payments related to net settlement of restricted stock units of $0.8 million and repurchases of Class A common stock under our share repurchase …
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-11
On May 12, 2026, we filed a patent infringement lawsuit in the Northern District of Illinois against Nanomics Biotechnology Co., Ltd. (“Nanomics”) (the “ND Ill. Action”), alleging infringement of five U.S. Patents, including U.S. Patent Nos. 11,435,360, 11,630,112, 12,050,222, 12,228,566, and 12,590…
On June 29, 2026, the ITC formally ordered institution of an investigation into the importation of Nanomics’ Accused Products into the United States and their infringement of the Asserted Patents. On July 21, 2026, the ND Ill. Action was ordered stayed pending the outcome of the ITC Action. An evide…
As a result of the ND Ill. and ITC Actions with Nanomics, and other as yet unforeseen litigation that may arise, we may incur substantial litigation costs in our attempts to recover or restrict use of our intellectual property.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice